| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee2b4cf5180521e069e04d91bced4ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c06536d381af40797437416dd3e055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_252e6bd9b6e2db70eac29acd07f3a9be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbd730dbba29c61d74b640023badfa3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89219e75ab0a70e5164970983a6dc8ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate |
2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af27f1af8c194b1dd578d966538cb7d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b73d1d41d49065d6ac32409d09c841fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c647cd76f5f46ca41e0e092033abc3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47300f222ab407d3d705b53982130284 |
| publicationDate |
2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8283161-B2 |
| titleOfInvention |
Tumour cell lines and uses thereof |
| abstract |
The present invention relates to a cell line selected from the group consisting of (a) a cell line denominated NM-F9 having the DSMZ accession number DSM ACC2606; (b) a cell line denominated NM-D4 having the DSMZ accession number DSM ACC2605; and subclones of (a) or (b). Additionally, the present invention provides a lysate of the cell lines or a molecule or mixture of molecules obtained from these cell lines as well as dendritic cells loaded with said lysate, co-cultivated or fused with cells from the cell lines, or a molecule or mixture of molecules obtained from these cell lines of the present invention. Moreover compositions, preferably pharmaceutical or vaccine compositions are provided which comprise the cell lines, lysate, molecules, mixture of molecules or dendritic cells of the present invention. In another aspect the present invention relates to methods for producing the aforementioned compositions. Furthermore, methods and uses for vaccination against or treatment or prevention of cancers and/or tumourous diseases are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280230-B2 |
| priorityDate |
2003-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |